do glp 1 cause gallbladder problems Diabetes Medicines Like GLP-1 Drugs Increase the Risk of Stones? Can GLP-1 Weight Loss Medications

No validated dosing, pharmacokinetics, or long-term safety There is no human pharmacokinetic data for injectable BPC-157: How long it lasts in the body What tissues it reaches Whether it accumulates How it is metabolized or excreted Long-term risks cannot be assessed without such information

A., Wassel, A., and Bixquert, M

Li and Hu, 2012) and, together with Axl, coregulates apoptotic and proliferative signaling (Qiu et al., 2012

For more on how glutathione supports skin health, see our glutathione for skin radiance article

Greathouse et al

After spending time on the FDA's Category 2 list flagged for "significant safety concerns" BPC-157 is now being removed from that restrictive classification and scheduled for a Pharmacy Compounding Advisory Committee (PCAC) review on July 23, 2026